Indofarma Bonds, 11.5% 20mar2018, IDR (INAF02AXMF, IDH0000240A7)
Domestic bonds
Domestic bonds
Everything you need for fixed income research and monitoring.
Explore the most comprehensive database
1 000 000
bonds
100 000
stocks
175 910
ETF & Funds
100 000
indices
Track your portfolio in the most efficient way
full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register|
As one of leading pharmaceutical companies in the Indonesia, PT. Indofarma (Persero), Tbk. has been serving the society for almost nine decades by providing quality pharmaceutical products. The root of the pharmaceutical company acknowledge as one ...
As one of leading pharmaceutical companies in the Indonesia, PT. Indofarma (Persero), Tbk. has been serving the society for almost nine decades by providing quality pharmaceutical products. The root of the pharmaceutical company acknowledge as one of pillars supporting national health system was Pabrik Obat Manggarai that was established in 1918 by the Dutch colonial administration.
In 2000, PT. Indofarma expanded downstrem into distribution and trading of pharmaceutical products and medical devices which name PT. Indofarma Global Medika. This allowed Indofarma to focus to its core business both in manufacturing and marketing of pharmaceutical products.
At present, Indofarma produces 229 items of pharmaceutical product, among them 53 are actively distributed in the market. Among the company's portofolio, 66 items are own brand products. Indofama produces generic products, over the counter products and traditional (herbal) products, and even food suplements.
To streghten its business structure, Indofarma strives to forge strategic alliances with international partners possesing needed branded products and/or technologies, both through the Holding and subsidiary company.
|
|
|
|
|
|
|
|
|
Explore the most comprehensive database
1 000 000
bonds
100 000
stocks
175 910
ETF & Funds
100 000
indices
Track your portfolio in the most efficient way
full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register